Improving nighttime healthcare access for children in Haiti
Novel Approach to Improve Patient Care and Diarrheal Disease Research Using Mobile Technology in Haiti
This study is testing a new telemedicine service called MotoMeds to see if it can help children in Haiti get better nighttime healthcare for their illnesses.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 7124 (estimated) |
| Ages | N/A to 10 Years |
| Sex | All |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gressier, Ouest) |
| Trial ID | NCT05480930 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance nighttime healthcare access for children in Haiti through a Telemedicine and Medication Delivery Service (TMDS) called MotoMeds. It evaluates the effectiveness of a digital clinical decision-support (dCDS) tool in improving adherence to treatment guidelines by TMDS providers. The study is based on previous research and involves assessing children under 10 years old who contact the service for acute illnesses. By analyzing pre- and post-implementation data, the study seeks to determine the impact of the dCDS tool on healthcare delivery in resource-limited settings.
Who should consider this trial
Good fit: Ideal candidates include children aged 10 years or younger with acute illnesses whose parents or guardians contact the TMDS for assistance.
Not a fit: Patients who do not provide consent or are older than 10 years may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly reduce pediatric mortality by ensuring timely treatment for common acute illnesses.
How similar studies have performed: Previous studies have shown promise in using telemedicine and decision-support tools in similar contexts, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria for child, parent/guardian participants: * Children 10 years of age or younger with an acute illness * Parent/guardian contacts the TMDS in regards to the illness during hours of operation * Parental/guardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent/assent at the household from the parent/guardian and child (7yrs and older) for participants who receive a household visit. Exclusion criteria for child, parent/guardian participants: * No consent
Where this trial is running
Gressier, Ouest
- CV Foundation — Gressier, Ouest, Haiti (Recruiting)
Study contacts
- Principal investigator: Eric J Nelson, MD PhD — University of Florida
- Study coordinator: Molly B Klarman, MPH
- Email: mklarman@ufl.edu
- Phone: 509 4600-7486
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.